Medication info

Lacetin MD Tablets

Prescription medicationTabletOralApproval withdrawn
Ingredient · strength
Tripotassium Bismuth Dicitrate›200mg / 1 tabletRanitidine Hydrochloride›168mg / 1 tabletSucralfate Hydrate›600mg / 1 tablet
Manufacturer / importer
Mothers Pharmaceutical Co., Ltd.
Appearance
Pale green oblong film-coated tablet
Packaging
For domestic use - 30 tablets/bottle - 30 tablets/bottle, For domestic use - 300 tablets/bottle - 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201905483 · Approved 2019.08.02

This product's status changed to Approval withdrawn on 2024.03.29. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related diseases (including ulcers, gastritis, and reflux esophagitis); prevention of Mendelson syndrome
Who takes it
Adults
Adult dose
○ Adults Usually, take 1 tablet orally twice daily, in the morning and at bedtime, without regard to meals. 1) Gastric and duodenal ulcers Administer 1 tablet per dose twice daily or 2 tablets per dose once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 2 tablets per dose twice daily, in the morning and at bedtime. The dose is also the same for concomitant therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks, and conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet per dose once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease Administer 1 tablet per dose twice daily for 8 weeks or 2 tablets per dose once daily at bedtime. However, the dose may be increased to 2 tablets per dose 4 times daily in patients with severe gastroesophageal reflux disease. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet per dose 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet per dose twice daily. 5) Preanesthetic medication (prevention of Mendelson's syndrome) Administer 1 tablet per dose 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet per dose on the night before surgery.

Ingredients

Manufacturer
Mothers Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related diseases (including ulcers, gastritis, and reflux esophagitis); prevention of Mendelson syndrome

  • Gastric and duodenal ulcers
  • gastritis
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson syndrome
  • post-surgical ulcers
  • gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs.
View approved original text

This medication is effectively used for treating gastrointestinal diseases, including ulcers of the stomach and duodenum, gastritis, gastroesophageal reflux disease, and Zollinger-Ellison syndrome. It also helps in the prevention and treatment of post-surgical ulcers and is used for gastric and duodenal ulcers caused by non-steroidal anti-inflammatory drugs (NSAIDs). It may also be administered prior to anesthesia to prevent Mendelson syndrome. This medication is helpful in improving various gastrointestinal diseases.

How to take

Adult dose

○ Adults Usually, take 1 tablet orally twice daily, in the morning and at bedtime, without regard to meals. 1) Gastric and duodenal ulcers Administer 1 tablet per dose twice daily or 2 tablets per dose once daily at bedtime. In particular, a higher cure rate may be achieved in patients with duodenal ulcers by administering 2 tablets per dose twice daily, in the morning and at bedtime. The dose is also the same for concomitant therapy to treat ulcers caused by nonsteroidal anti-inflammatory drugs or to prevent gastric and duodenal ulcers during long-term use of nonsteroidal anti-inflammatory drugs. These conditions usually heal within 4 weeks, and conditions caused by nonsteroidal anti-inflammatory drugs usually heal within 8 weeks, although healing may occasionally take longer in some patients. For patients with recurrent ulcers who responded well to short-term treatment with this medicine, administer 1 tablet per dose once daily at bedtime as maintenance therapy. 2) Gastroesophageal reflux disease Administer 1 tablet per dose twice daily for 8 weeks or 2 tablets per dose once daily at bedtime. However, the dose may be increased to 2 tablets per dose 4 times daily in patients with severe gastroesophageal reflux disease. 3) Zollinger-Ellison syndrome Initiate treatment with an initial dose of 1 tablet per dose 3 times daily; the dose may be increased as needed. In severe cases, up to 6 g of ranitidine daily may be administered as directed by a physician. 4) Upper gastrointestinal bleeding due to peptic ulcers, acute stress ulcers, and acute gastric mucosal lesions When oral administration becomes possible, switch from injection to oral administration and administer 1 tablet per dose twice daily. 5) Preanesthetic medication (prevention of Mendelson's syndrome) Administer 1 tablet per dose 2 hours before induction of anesthesia. In this case, it is preferable to also administer 1 tablet per dose on the night before surgery.

Precautions

This medication should not be used in patients undergoing dialysis treatment. Patients who have experienced an allergic reaction to this medication or its components should avoid taking it. This medication should not be administered to patients with a history of acute porphyria, as it may worsen their symptoms. Patients with kidney function problems or renal impairment should avoid using this medication. Patients who have undergone upper gastrointestinal surgery should also avoid using this medication. Women who are pregnant or may become pregnant should not take this medication. The safety of this medication has not been established in premature infants or neonates, so it should not be administered to them. Patients on a potassium-restricted diet should also avoid using this medication. Patients with liver function problems should use this medication with caution, and those with a history of drug allergies should also be careful. Elderly patients or those with a history of renal impairment require more careful monitoring when taking this medication. Patients taking non-steroidal anti-inflammatory drugs, particularly elderly patients or those with a history of peptic ulcers, should undergo regular check-ups. This medication may mask symptoms of stomach cancer, so patients with gastric ulcers or middle-aged patients who have newly developed dyspeptic symptoms should confirm malignancy before use. Patients with Helicobacter pylori infection and gastric or duodenal ulcers need eradication therapy. Care should be taken when administering this medication to severely ill ICU patients due to the risk of gastric stone formation. Patients with hypophosphatemia should be cautious, as this medication's components may interfere with phosphate absorption. Patients with swallowing difficulties may have a risk of respiratory complications after taking this medication, so caution is needed. During administration of this medication, very rarely, severe allergic reactions such as anaphylactic shock may occur, so the administration should be stopped and medical personnel notified immediately if symptoms appear. Allergic symptoms such as skin rash, hives, angioedema, fever, bronchospasm, and hypotension may also occur rarely, and administration should be discontinued if these symptoms appear. Blood tests may rarely show abnormalities in blood counts, such as leukopenia or thrombocytopenia, and immediate consultation with a physician is required if symptoms occur. Rarely, liver function abnormalities may occur, and administration should be discontinued if jaundice or hepatitis symptoms appear. Cardiac arrhythmias or irregular heartbeats have been reported very rarely, so patients with heart disease should exercise caution. Gastrointestinal side effects such as nausea, vomiting, constipation, diarrhea, and abdominal pain may occur but are generally mild. Neurological side effects such as dizziness, drowsiness, confusion, and seizures may occur very rarely, and administration should be discontinued if symptoms are severe. Endocrine disorders such as gynecomastia, erectile dysfunction, and decreased libido have been reported very rarely. Muscle pain or joint pain may occur rarely, and if severe, administration should be stopped immediately. Skin rash or hair loss may occur rarely. It is advisable not to use this medication for an extended period, and if no therapeutic effect is observed, a switch to another medication should be made. Elderly patients or those with chronic illnesses may have an increased risk of pneumonia, so caution is required. If dizziness or drowsiness occurs during administration, it is advised to avoid driving or operating dangerous machinery. This medication may interact with other drugs, so if other medications are being taken, medical personnel should be consulted. It is safest for pregnant or nursing women not to take this medication. The safety of this medication in children has not been established, so it's not recommended for pediatric use. In case of overdose, treatments such as vomiting or gastric lavage may be necessary; in severe cases, hemodialysis may be beneficial. This medication may reduce gastric acid secretion, promoting bacterial growth in the gastrointestinal tract, so ocular examinations may be necessary with long-term use.

Side effects

  • Anaphylactic shock
  • skin rash
  • urticaria
  • angioedema
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • granulocytopenia
  • leukopenia
Show 59 more
  • thrombocytopenia
  • elevated serum creatinine
  • elevated serum aminotransferases
  • agranulocytosis
  • pancytopenia
  • myelosuppression
  • aplastic anemia
  • aplastic anemia
  • acquired immune hemolytic anemia
  • eosinophilia
  • elevated AST
  • elevated ALT
  • elevated r-GTP
  • elevated ALP
  • jaundice hepatitis
  • non-jaundice hepatitis
  • tachycardia
  • bradycardia
  • heart block
  • premature ventricular contractions
  • arrhythmia
  • vasculitis
  • nausea
  • vomiting
  • constipation
  • diarrhea
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • dizziness
  • drowsiness
  • confusion
  • convulsions
  • excitation
  • insomnia
  • headache
  • heaviness in the head
  • malaise
  • anxiety
  • mental confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movements
  • altered consciousness
  • muscular cramps
  • gynecomastia
  • galactorrhea
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature. This will help preserve the medication's efficacy for a longer period.

Appearance and packaging

Appearance

Pale green oblong film-coated tablet

Package unit

For domestic use - 30 tablets/bottle - 30 tablets/bottle, For domestic use - 300 tablets/bottle - 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.